Clinical trial
Forxiga Tablets General Drug Use-Results Study in Patients With HF
NCT04865406 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Forxiga Tablets General Drug Use-Results Study in Patients With HF
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 10, 2021
- Completion date
- August 22, 2024
- Enrollment
- 1,221 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.